JRNYS review
An independent look at JRNYS: what it charges, which medications it prescribes, how it verifies, and who it suits.
No FDA warning letter on file for JRNYS in the warning letter register this site maintains from the FDA’s published list.
What you are buying
Premium GLP-1 prescription programs. JRNYS prescribes Compounded tirzepatide as injection. It prescribes brand-name products only — the FDA-approved versions, made by the manufacturer. It ships to all 50 states — Terms state 'The Platform Services and Telehealth Services are currently accessible only to individuals in states where such services are offered.' No count or list is published.
JRNYS bills insurance, so what you pay depends on your plan as well as on the price below. The medication is billed separately from the programme fee. It does not publish which pharmacy fills its prescriptions.
What the medication actually costs
Context before the programme price: what a pharmacy pays to acquire the branded equivalent. JRNYS sets its own price on top of a compounded or branded supply.
Source: CMS NADAC. This is what pharmacies pay, not a retail price and not what you would be charged.
Plans and what they cost
Every price is the lowest we can verify for that medication, normalised to one month so a prepay plan compares honestly against a monthly one.
Last read Aug 13, 2026 from the provider’s own site. The page we read
The catch: Highest price point at $365/month.
What three months really costs
A discounted first month makes a programme look cheaper than it is. This is that month plus two at the standing rate.
Medication only, at the lowest verified rate. Any membership or consultation fee is listed separately above and is not in this total.
What is included
How it checks out
| Check | What we found | Source |
|---|---|---|
| Partner pharmacy | Not published | Provider site |
| LegitScript | Certification badge displayed | Provider site |
| States served | All 50 states — Terms state 'The Platform Services and Telehealth Services are currently accessible only to individuals in states where such services are offered.' No count or list is published. | Provider site |
| Cancellation | Cancel anytime | Provider terms |
The safety record
We hold no FDA warning letter against JRNYS. That is an absence of enforcement, not a clearance — the checks above are what we can actually verify.
The honest scorecard
Strong JRNYS alternatives
JRNYS FAQ
In this section (1)
- CMS NADACNational Average Drug Acquisition Cost, weekly file
- CMS Medicare Part DPrescriber public use file, by geography and drug
- CMS State Drug UtilizationQuarterly Medicaid prescription and reimbursement data
NADAC figures are pharmacy acquisition costs, not retail prices and not what you will pay. This content is educational and is not medical advice.